Cargando…

Assessment of Antibody Interference of Enfuvirtide (T20) Function Shows Assay Dependent Variability

BACKGROUND: During HIV infection, fusion of the viral and cellular membranes is dependent on folding of the gp41 trimer into a six-helix bundle. Fusion inhibitors, such as the antiretroviral Enfuvirtide (T20), interfere with the formation of the gp41 six-helix bundle. Recent in vitro studies reveal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Michele, Hoffman, Jonathon, Sojar, Hakimuddin, Aalinkeel, Ravikumar, Hsiao, Chiu-Bin, Hicar, Mark Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710457/ https://www.ncbi.nlm.nih.gov/pubmed/30836922 http://dx.doi.org/10.2174/1570162X17666190228154850

Ejemplares similares

1611 Antibodies to conformational epitopes interfere with T20 fusion inhibition
por: Sojar, Hakimuddin, et al.
Publicado: (2014)

641. Development of Structural Epitope Targeting During B-cell Ontogeny by Exploration of Relatives of Gp41 Structural Epitope Binding Antibody 6F5
por: Baron, Sarah, et al.
Publicado: (2018)

Highly mutated monoclonal antibody 3F2 targets a conformational and strain-restricted epitope in human immunodeficiency virus gp41 with significant antibody-dependent cell cytotoxicity
por: DeCotes, Devin, et al.
Publicado: (2022)

406. Cloning Antibodies Against Kawasaki Disease from Acute Plasmablast Responses
por: Baron, Sarah, et al.
Publicado: (2019)

274. Potential HIV vaccine gp41 epitope targeting antibodies identify peptides with similarity to proposed Kawasaki disease related peptide, suggesting non-specific mimotope targeting of acidic amino acid enriched regions
por: Hakimuddin, Sojar, et al.
Publicado: (2023)

Human Antibodies that Recognize Novel Immunodominant Quaternary Epitopes on the HIV-1 Env Protein
por: Hicar, Mark D., et al.
Publicado: (2016)

Enfuvirtide antiretroviral therapy in HIV-1 infection
por: Kitchen, Christina MR, et al.
Publicado: (2008)

Enfuvirtide in therapy at patients with HIV-infection and tuberculosis
por: Kravchenko, AV, et al.
Publicado: (2010)

Enfuvirtide biosynthesis in thermostable chaperone-based fusion
por: Zenin, Vladimir, et al.
Publicado: (2022)

Modulations of human placental transfer of lopinavir, ritonavir and enfuvirtide
por: Ceccaldi, Pierre-François, et al.
Publicado: (2010)

Synergistic anti-HIV-1 activity of griffithsin with tenofovir, maraviroc and enfuvirtide
por: Férir, Geoffrey, et al.
Publicado: (2011)

Massively Parallel Profiling of HIV-1 Resistance to the Fusion Inhibitor Enfuvirtide
por: Dingens, Adam S., et al.
Publicado: (2019)

Characterization of Gp41 Polymorphisms in the Fusion Peptide Domain and T-20 (Enfuvirtide) Resistance-Associated Regions in Korean HIV-1 Isolates
por: Jang, Dai-Ho, et al.
Publicado: (2014)

T20QoL: an observational multicenter cohort study to evaluate the quality of life in HIV-patients treated with enfuvirtide (ENF, T-20) in combination with an optimized background therapy
por: Bucciardini, R, et al.
Publicado: (2008)

A Blast From the Past: Abdominal Wall Amyloidosis Due to Enfuvirtide Injections
por: Costiniuk, Cecilia, et al.
Publicado: (2023)

HIV-1 Fusion Inhibitor Peptides Enfuvirtide and T-1249 Interact with Erythrocyte and Lymphocyte Membranes
por: Matos, Pedro M., et al.
Publicado: (2010)

Enfuvirtide−PEG conjugate: A potent HIV fusion inhibitor with improved pharmacokinetic properties
por: Cheng, Shuihong, et al.
Publicado: (2016)

Fusion inhibitors and their evolving role during salvage antiretroviral therapy. Seven years of experience with enfuvirtide
por: Manfredi, Roberto
Publicado: (2010)

Sphingopeptides: dihydrosphingosine‐based fusion inhibitors against wild‐type and enfuvirtide‐resistant HIV‐1
por: Ashkenazi, Avraham, et al.
Publicado: (2012)

Effectiveness of enfuvirtide in a cohort of highly antiretroviral-experienced HIV-1-infected patients in Mexico
por: Huerta-García, Gloria, et al.
Publicado: (2014)

Thermostable chaperone-based polypeptide biosynthesis: Enfuvirtide model product quality and protocol-related impurities
por: Zenin, Vladimir, et al.
Publicado: (2023)

Neuroprotective role of galectin-1 in central nervous system pathophysiology
por: Aalinkeel, Ravikumar, et al.
Publicado: (2016)

Action of enfuvirtide on the pregnancy of albino rats ( Rattus norvegicus albinus, Rodentia, Mammalia ): biological assay and functional and histological analyses of exposed maternal-fetal organs
por: de Moraes, Renata Delphim, et al.
Publicado: (2023)

Short-course intensification with enfuvirtide in virologic failure: impact on intracellular HIV reservoir and on viral tropism (INNOVE study)
por: Ghosn, J, et al.
Publicado: (2010)

In Vitro Selection and Characterization of HIV-1 Variants with Increased Resistance to LP-40, Enfuvirtide-Based Lipopeptide Inhibitor
por: Hu, Yue, et al.
Publicado: (2022)

Antibodies and Immunity During Kawasaki Disease
por: Hicar, Mark Daniel
Publicado: (2020)

Telomere Length Shortening in Microglia: Implication for Accelerated Senescence and Neurocognitive Deficits in HIV
por: Hsiao, Chiu-Bin, et al.
Publicado: (2021)

Misleading FT4 measurement: Assay-dependent antibody interference
por: Revet, Ingrid, et al.
Publicado: (2016)

Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration: Randomized crossover clinical trial in healthy volunteers
por: Barroso, Sergio, et al.
Publicado: (2019)

Development of a HPLC fluorometric method for the quantification of enfuvirtide following in vitro releasing studies on thermosensitive in situ forming gel
por: Li, Huanhuan, et al.
Publicado: (2023)

1008. Presence of Antibody Dependent Cell Cytotoxicity (ADCC) Functional Antibodies that Target a Complex Gp41 Epitope Correlates with Long-term Non-progression and ADCC is Maintained with Mutants Using Germline Heavy Chain Variable Gene Sequence of VH1-02 Gene
por: Baron, Sarah, et al.
Publicado: (2021)

A Novel Class of Anti-HIV Agents with Multiple Copies of Enfuvirtide Enhances Inhibition of Viral Replication and Cellular Transmission In Vitro
por: Chang, Chien-Hsing, et al.
Publicado: (2012)

Improved Pharmacological and Structural Properties of HIV Fusion Inhibitor AP3 over Enfuvirtide: Highlighting Advantages of Artificial Peptide Strategy
por: Zhu, Xiaojie, et al.
Publicado: (2015)

The improved efficacy of Sifuvirtide compared with enfuvirtide might be related to its selectivity for the rigid biomembrane, as determined through surface plasmon resonance
por: Cao, Ping, et al.
Publicado: (2017)

Cardiac troponin T quantitative assay failure as a result of antibody interference
por: Fortgens, Philip H., et al.
Publicado: (2013)

257. Shared antibody sequences reveal novel public clonotypes of antibodies within and between HIV infected and healthy individuals
por: Chang, Arthur, et al.
Publicado: (2023)

B Cells and Antibodies in Kawasaki Disease
por: Lindquist, Michael E., et al.
Publicado: (2019)

PO262 / #255 NEUROMODULATORY EFFECTS OF SARS-COV2 ON BLOOD BRAIN BARRIER INTEGRITY AND FUNCTION: E-POSTER VIEWING
por: Clough, Erin, et al.
Publicado: (2022)

Combination Modality Using Quercetin to Enhance the Efficacy of Docetaxel in Prostate Cancer Cells
por: Sharma, Satish, et al.
Publicado: (2023)

Impact of the HIV-1 env Genetic Context outside HR1–HR2 on Resistance to the Fusion Inhibitor Enfuvirtide and Viral Infectivity in Clinical Isolates
por: Baatz, Franky, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_do51u12h3d1nenne5s0hu9e0hg